First AD

Second AD

Expert Derek Lyle MD provides an in-depth overview of biomarker testing and targeted therapy in the current landscape of non–small cell lung cancer management.

Biomarker Testing and Targeted Therapy in NSCLC: Review and Update

Sponsored

® Sponsored section encompasses all sponsored content that is presented as articles, video interviews, webinars, blog posts, and more across various types of malignancies, including breast cancer, lung cancer, hematologic cancers, gynecologic cancers, gastrointestinal cancers, genitourinary cancers, and more. 

Expert Derek Lyle, MD, provides an in-depth overview of biomarker testing and targeted therapy in the current landscape of non–small cell lung cancer management.